KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to 22.42%.

  • Dynavax Technologies' EBIT Margin rose 99200.0% to 22.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.16%, marking a year-over-year increase of 73700.0%. This contributed to the annual value of 1.49% for FY2024, which is 144500.0% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' EBIT Margin is 22.42%, which was up 99200.0% from 15.12% recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' EBIT Margin registered a high of 50.0% during Q2 2022, and its lowest value of 64.46% during Q1 2023.
  • Moreover, its 5-year median value for EBIT Margin was 14.84% (2021), whereas its average is 8.57%.
  • As far as peak fluctuations go, Dynavax Technologies' EBIT Margin surged by 8921600bps in 2021, and later tumbled by -914500bps in 2023.
  • Dynavax Technologies' EBIT Margin (Quarter) stood at 41.38% in 2021, then decreased by -17bps to 34.22% in 2022, then plummeted by -145bps to 15.27% in 2023, then surged by 85bps to 2.27% in 2024, then skyrocketed by 1090bps to 22.42% in 2025.
  • Its EBIT Margin was 22.42% in Q3 2025, compared to 15.12% in Q2 2025 and 34.67% in Q1 2025.